Tau neurofibrillary pathology and microtubule stability

Journal of Molecular Neuroscience

Volumn 19, Issue 3, 2002, Pages 289-293

  Michaelis, Mary L ^a   Dobrowsky, Rick T ^a   Li, Guibin ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Cdk5 p25; Cyclin dependent kinase 5; Primary neurons; Tau kinase; Tau phosphorylation; Taxol

Indexed keywords

AMYLOID BETA PROTEIN; CALPAIN; CYCLIN DEPENDENT KINASE 5; PACLITAXEL; PROTEIN P25; PROTEIN P35; TAU PROTEIN;

ALZHEIMER DISEASE; BIOSENSOR; CELL SURVIVAL; CYTOSKELETON; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SUBSTRATE; FIBER; HUMAN; MICROTUBULE; NERVE CELL; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOLOGY; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN; ANIMALS; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; ENZYME ACTIVATION; HUMANS; MICROTUBULES; NEUROFIBRILLARY TANGLES; PACLITAXEL; PHOSPHORYLATION; TAU PROTEINS;

EID: 0036931159     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:19:3:289     Document Type: Review

References (25)

1. Ahlijanian M. K., Barrezueta N. X., Williams R. D., Jakowski A., Kowsz K. P., McCarthy S., et al. (2000) Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc. Natl. Acad. Sci. USA 97, 2910-2915.
2. Alvarez A., Munoz J. P., and Maccioni R. B. (2001) A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. Exp. Cell Res. 264, 266-274.
3. Alvarez A., Toro R., Caceres A., and Maccioni R. B. (1999) Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death. FEBS Lett. 459, 421-426.
4. Billingsley M. L. and Kincaid R. L. (1997) Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem. J. 323, 577-591.
5. Busciglio J., Lorenzo A., Yeh J., and Yanker B. A. (1995) β-Amyloid fibrils induce Tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888.
6. Chen Y., Moore-Nichols D., Robertson T., Bechtel M., and Michaelis M. L. (1999) Effects of Aβ and microtubule-stabilizing drugs on the microtubule network in primary neurons. Soc. Neurosci. Abstr. 25, 2125.
7. Chen Y., Liu Y., Reiff E., Himes R., Georg G., and Michaelis M. L. (2000) Protection of primary neurons against Aβ-induced toxicity by structurally diverse microtubule-stabilizing drugs. Soc. Neurosci. 26, 664.13.
8. Chen Y., Hill S., Faibushevich A., and Michaelis M. L. (2001) Effects of Taxol on Aβ-induced activation of caspase-8 in primary neurons. Soc. Neurosci. Abstr. 27, 963.1.
9. Dhavan R. and Tsai L. H. (2001) A decade of cdk5. Nat. Rev. Mol. Cell. Biol. 2, 749-759.
10. Hutton M., Lendon C. L., Rizzu P., Baker M., Froelich S., Houlden H., et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
11. Jackson G. R., Wiedau-Pazos M., Sang T.-K., Wagle N., Brown C. A., Massachi S., et al. (2002) Human wild-type Tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509-519.
12. Lee K. Y., Clark A. W., Rosales J. L., Chapman K., Fung T., and Johnston R. N. (1999) Elevated neuronal Cdc2-1ike kinase activity in the Alzheimer disease brain. Neurosci. Res. 34, 21-29.
13. Lee M. S., Kwon Y. T., Li M., Peng J., Friedlander R. M., and Tsai L. H. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364.
14. Lee V. M., Daughenbaugh R., and Trojanowski J. Q. (1994) Microtubule stabilizing drugs for the treatment of Alzheimer's disease. Neurobiol. Aging 2(Suppl.), S87-S89.
15. Michaelis M. L., Ranciat N., Chen Y., Bechtel M., Ragan R., Hepperle M., et al. (1998a) Protection against β-amyloid toxicity in primary neurons by paclitaxel [Taxol®]. J. Neurochem. 70, 1623-1627.
16. Michaelis M. L., Chen Y., and Ranciat N. (1998b) Microtubule stabilization and protection against apoptosis in primary neurons. Soc. Neurosci. 24, 1457.
17. Niethammer M., Smith D. S., Ayala R., Peng J., Ko J., Lee M. S., et al. (2000) NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 28, 697-711.
18. Patrick G. N., Zukerberg L., Nikolic M., de La Monte S., Dikkes P., and Tsai L. H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
19. Patzke and Tsai (2002). Calpain-medicated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J. Biol. Chem. 277, 8054-8060.
20. Selkoe D. J. (2001) Clearing the brain's amyloid cobwebs. Neuron 32, 177-180.
21. Sobue K., Agarwal-Mawal A., Li W., Sun W., Miura Y., and Paudel H. K. (2000) Interaction of neuronal Cdc2-1ike protein kinase with microtubule-associated protein tau. J. Biol. Chem. 275, 16,673-16,680.
22. Spillantini M. G., Murrell J. R., Goedert M., Farlow M. R., Klug A., and Ghetti B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA 95, 7737-7741.
23. Taniguchi S., Fujita Y., Hayashi S., Kakita A., Takahashi H., Murayama S., et al. (2001) Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett. 489, 46-50.
24. Trojanowski J. Q. and Lee V. M. (2000) "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann. NY Acad. Sci. 924, 62-67.
25. Yoo B. C. and Lubec G. (2001) p25 protein in neurodegeneration. Nature 411, 763-764.